posted on 2022-08-24, 07:21authored byAnamika Sharma, Ashish Kumar, Beatriz G. de la Torre, Fernando Albericio
Since the last century, peptides have gained wide acceptance
as
drugs, with almost 100 already in the market and a large number in
the pipeline. In this context, peptide synthesis has grown massively
as a stringent field for pharmaceuticals around the globe. Three methodologies,
namely, classical solution peptide synthesis (CSPS), solid-phase peptide
synthesis (SPPS), and liquid-phase peptide synthesis (LPPS), have
made significant contributions to the field. This review provides
a comprehensive and integrated vision of LPPS as the third wave for
peptide synthesis. LPPS combines the advantages of CSPS and SPPS,
where peptide elongation is carried out in solution and the growing
peptide chain is supported on a soluble tag, which confers characteristic
properties. LPPS protocols allow the large-scale production of peptides
and reduce the use of excess reagents and solvents, thus meeting the
principles of green chemistry. In this review, tags associated with
LPPS are broadly discussed under the following headings: polydisperse
polyethylene glycol (PEG), membrane-enhanced peptide synthesis (MEPS),
fluorous technology, ionic liquids (ILs), PolyCarbon, hydrophobic
polymers, and group-assisted purification (GAP). It also highlights
the signature accomplishments of LPPS tags and the limitations of
the same.